{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:22:28Z","timestamp":1787876548101,"version":"build-2784847793"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T00:00:00Z","timestamp":1590451200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T00:00:00Z","timestamp":1590451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The gonadotropin releasing hormone agonist (GnRH-a) long-protocols and the GnRH-antagonist protocols are two commonly used protocols for <jats:italic>in vitro<\/jats:italic> fertilization (IVF), but their cost-effectiveness has not been studied, especially in China. A retrospective study involving 1638 individuals in GnRH-a long-protocol and 621 in GnRH-antagonist protocol were conducted and a decision tree model analysis was used to analyze the cost-effectiveness. Both direct and indirect costs were calculated. As a result, during the fresh embryo transplantation cycles, there was no significant difference in the rate of ongoing pregnancy between the two protocols, the average cost of per ongoing pregnancy in the GnRH-antagonist protocol was $ 16970.85, and that in the GnRH-agonist long-protocol was $19902.24. The probability of cumulative ongoing pregnancy per start cycle was estimated at 60.65% for the GnRH-antagonist protocol and 71.6% for the GnRH-agonist long-protocol (P\u2009&lt;\u20090.01). Considering the cumulative ongoing pregnancy rate, the mean costs per ongoing pregnancy were estimated at $8176.76 and at $7595.28 with GnRH-antagonist protocol and GnRH-agonist long protocol, respectively. In conclusion, in fresh embryo transplantation cycle, the GnRH-antagonist protocol has economic advantage. However, the GnRH-agonist long protocol is more cost effective considering the cumulative ongoing pregnancy rate in the fresh embryo and frozen embryo transplantation cycles.<\/jats:p>","DOI":"10.1038\/s41598-020-65558-0","type":"journal-article","created":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T10:02:38Z","timestamp":1590487358000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Cost-effectiveness analysis of GnRH-agonist long-protocol and GnRH-antagonist protocol for in vitro fertilization"],"prefix":"10.1038","volume":"10","author":[{"given":"Miaomiao","family":"Jing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiufang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youbing","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runju","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,26]]},"reference":[{"issue":"12","key":"65558_CR1","doi-asserted-by":"publisher","first-page":"e1001356","DOI":"10.1371\/journal.pmed.1001356","volume":"9","author":"Maya N. Mascarenhas","year":"2012","unstructured":"Mascarenhas, M. N., Flaxman, S. R., Boerma, T., Vanderpoel, S. & Stevens, G. A. National, Regional, and Global Trends in Infertility Prevalence Since 1990: A Systematic Analysis of 277 Health Surveys. PLoS Med 9, e1001356, https:\/\/doi.org\/10.1371\/journal.pmed.1001356 (2012).","journal-title":"PLoS Medicine"},{"key":"65558_CR2","unstructured":"European Society of Human Reproduction and Embryology. More than 8 million babies born from IVF since the world\u2019s first in 1978., (2018)."},{"key":"65558_CR3","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.fertnstert.2018.04.039","volume":"110","author":"NP Polyzos","year":"2018","unstructured":"Polyzos, N. P. et al. Cumulative live birth rates according to the number of oocytes retrieved after the first ovarian stimulation for in vitro fertilization\/intracytoplasmic sperm injection: a multicenter multinational analysis including approximately 15,000 women. Fertility and sterility 110, 661\u2013670. e661, https:\/\/doi.org\/10.1016\/j.fertnstert.2018.04.039 (2018).","journal-title":"Fertility and sterility"},{"issue":"Suppl 1","key":"65558_CR4","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.1016\/j.ejogrb.2004.01.033","volume":"115","author":"ME Coccia","year":"2004","unstructured":"Coccia, M. E., Comparetto, C., Bracco, G. L. & Scarselli, G. GnRH antagonists. European journal of obstetrics, gynecology, and reproductive biology 115(Suppl 1), S44\u201356, https:\/\/doi.org\/10.1016\/j.ejogrb.2004.01.033 (2004).","journal-title":"European journal of obstetrics, gynecology, and reproductive biology"},{"key":"65558_CR5","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/S0015-0282(16)49159-4","volume":"45","author":"RC Fleming","year":"1986","unstructured":"Fleming, R. C. J. R. Induction of multiple follicular growth in normally menstruating women with endogenous gonadotropin suppression. Fertility and sterility 45, 226\u2013230 (1986).","journal-title":"Fertility and sterility"},{"key":"65558_CR6","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1093\/humrep\/dem270","volume":"22","author":"JA Huirne","year":"2007","unstructured":"Huirne, J. A., Homburg, R. & Lambalk, C. B. Are GnRH antagonists comparable to agonists for use in IVF? Human reproduction (Oxford, England) 22, 2805\u20132813, https:\/\/doi.org\/10.1093\/humrep\/dem270 (2007).","journal-title":"Human reproduction (Oxford, England)"},{"key":"65558_CR7","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1093\/oxfordjournals.humrep.a138597","volume":"9","author":"K Diedrich","year":"1994","unstructured":"Diedrich, K. et al. Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation. Human reproduction (Oxford, England) 9, 788\u2013791 (1994).","journal-title":"Human reproduction (Oxford, England)"},{"key":"65558_CR8","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1210\/jcem-67-3-524","volume":"67","author":"JE Hall","year":"1988","unstructured":"Hall, J. E. et al. Evidence of differential control of FSH and LH secretion by gonadotropin-releasing hormone (GnRH) from the use of a GnRH antagonist. The Journal of clinical endocrinology and metabolism 67, 524\u2013531, https:\/\/doi.org\/10.1210\/jcem-67-3-524 (1988).","journal-title":"The Journal of clinical endocrinology and metabolism"},{"key":"65558_CR9","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S1472-6483(10)60337-9","volume":"15","author":"W Ombelet","year":"2007","unstructured":"Ombelet, W. & Campo, R. Affordable IVF for developing countries. Reproductive biomedicine online 15, 257\u2013265 (2007).","journal-title":"Reproductive biomedicine online"},{"key":"65558_CR10","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.fertnstert.2007.03.003","volume":"89","author":"CA Bouwmans","year":"2008","unstructured":"Bouwmans, C. A. et al. A detailed cost analysis of in vitro fertilization and intracytoplasmic sperm injection treatment. Fertility and sterility 89, 331\u2013341, https:\/\/doi.org\/10.1016\/j.fertnstert.2007.03.003 (2008).","journal-title":"Fertility and sterility"},{"key":"65558_CR11","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/j.fertnstert.2012.12.045","volume":"99","author":"LM Moolenaar","year":"2013","unstructured":"Moolenaar, L. M. et al. Economic evaluation studies in reproductive medicine: a systematic review of methodologic quality. Fertility and sterility 99, 1689\u20131694, https:\/\/doi.org\/10.1016\/j.fertnstert.2012.12.045 (2013).","journal-title":"Fertility and sterility"},{"key":"65558_CR12","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/j.fertnstert.2009.06.020","volume":"94","author":"AD Domar","year":"2010","unstructured":"Domar, A. D., Smith, K., Conboy, L., Iannone, M. & Alper, M. A prospective investigation into the reasons why insured United States patients drop out of in vitro fertilization treatment. Fertility and sterility 94, 1457\u20131459, https:\/\/doi.org\/10.1016\/j.fertnstert.2009.06.020 (2010).","journal-title":"Fertility and sterility"},{"key":"65558_CR13","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.fertnstert.2009.07.990","volume":"94","author":"SM Mourad","year":"2010","unstructured":"Mourad, S. M. et al. Determinants of patients\u2019 experiences and satisfaction with fertility care. Fertility and sterility 94, 1254\u20131260, https:\/\/doi.org\/10.1016\/j.fertnstert.2009.07.990 (2010).","journal-title":"Fertility and sterility"},{"key":"65558_CR14","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/j.fertnstert.2009.08.066","volume":"94","author":"AJ van Dongen","year":"2010","unstructured":"van Dongen, A. J., Verhagen, T. E., Dumoulin, J. C., Land, J. A. & Evers, J. L. Reasons for dropping out from a waiting list for in vitro fertilization. Fertility and sterility 94, 1713\u20131716, https:\/\/doi.org\/10.1016\/j.fertnstert.2009.08.066 (2010).","journal-title":"Fertility and sterility"},{"key":"65558_CR15","first-page":"257","volume":"28","author":"XY Zheng","year":"2012","unstructured":"Zheng, X. Y. & Disease, Q. Y. burden of infertility in China. Chin J Public Health 28, 257\u2013260 (2012).","journal-title":"Chin J Public Health"},{"key":"65558_CR16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.rbmo.2012.11.001","volume":"26","author":"R Orvieto","year":"2013","unstructured":"Orvieto, R. & Patrizio, P. GnRH agonist versus GnRH antagonist in ovarian stimulation: an ongoing debate. Reproductive biomedicine online 26, 4\u20138, https:\/\/doi.org\/10.1016\/j.rbmo.2012.11.001 (2013).","journal-title":"Reproductive biomedicine online"},{"key":"65558_CR17","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.rbmo.2014.05.007","volume":"29","author":"D Grow","year":"2014","unstructured":"Grow, D. et al. GnRH agonist and GnRH antagonist protocols: comparison of outcomes among good-prognosis patients using national surveillance data. Reproductive biomedicine online 29, 299\u2013304, https:\/\/doi.org\/10.1016\/j.rbmo.2014.05.007 (2014).","journal-title":"Reproductive biomedicine online"},{"key":"65558_CR18","doi-asserted-by":"publisher","first-page":"e0175985","DOI":"10.1371\/journal.pone.0175985","volume":"12","author":"RL Wang","year":"2017","unstructured":"Wang, R. L., Lin, S. R., Wang, Y., Qian, W. P. & Zhou, L. Comparisons of GnRH antagonist protocol versus GnRH agonist long protocol in patients with normal ovarian reserve: A systematic review and meta-analysis. PloS one 12, e0175985, https:\/\/doi.org\/10.1371\/journal.pone.0175985 (2017).","journal-title":"PloS one"},{"key":"65558_CR19","doi-asserted-by":"publisher","first-page":"Cd001750","DOI":"10.1002\/14651858.CD001750.pub4","volume":"4","author":"HG Al-Inany","year":"2016","unstructured":"Al-Inany, H. G. et al. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. The Cochrane database of systematic reviews 4, Cd001750, https:\/\/doi.org\/10.1002\/14651858.CD001750.pub4 (2016).","journal-title":"The Cochrane database of systematic reviews"},{"key":"65558_CR20","doi-asserted-by":"publisher","first-page":"e15492","DOI":"10.1097\/md.0000000000015492","volume":"98","author":"W Pan","year":"2019","unstructured":"Pan, W. et al. Decision analysis about the cost-effectiveness of different in vitro fertilization-embryo transfer protocol under considering governments, hospitals, and patient. Medicine 98, e15492, https:\/\/doi.org\/10.1097\/md.0000000000015492 (2019).","journal-title":"Medicine"},{"key":"65558_CR21","unstructured":"National Health Commission. China health statistics yearbook 2018 115 (China union medical university press (2018)."},{"key":"65558_CR22","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1093\/humupd\/8.3.265","volume":"8","author":"J Collins","year":"2002","unstructured":"Collins, J. An international survey of the health economics of IVF and ICSI. Human reproduction update 8, 265\u2013277 (2002).","journal-title":"Human reproduction update"},{"key":"65558_CR23","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/humupd\/dmx017","volume":"23","author":"CB Lambalk","year":"2017","unstructured":"Lambalk, C. B. et al. GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type. Human reproduction update 23, 560\u2013579, https:\/\/doi.org\/10.1093\/humupd\/dmx017 (2017).","journal-title":"Human reproduction update"},{"key":"65558_CR24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.5653\/cerm.2017.44.2.57","volume":"44","author":"N Chappell","year":"2017","unstructured":"Chappell, N. & Gibbons, W. E. The use of gonadotropin-releasing hormone antagonist post-ovulation trigger in ovarian hyperstimulation syndrome. Clinical and experimental reproductive medicine 44, 57\u201362, https:\/\/doi.org\/10.5653\/cerm.2017.44.2.57 (2017).","journal-title":"Clinical and experimental reproductive medicine"},{"key":"65558_CR25","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1093\/humrep\/dev163","volume":"30","author":"ESHRE Capri Workshop Group.","year":"2015","unstructured":"ESHRE Capri Workshop Group. Economic aspects of infertility care: a challenge for researchers and clinicians. Human reproduction (Oxford, England) 30, 2243\u20132248, https:\/\/doi.org\/10.1093\/humrep\/dev163 (2015).","journal-title":"Human reproduction (Oxford, England)"},{"key":"65558_CR26","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.fertnstert.2017.09.020","volume":"109","author":"M Toftager","year":"2018","unstructured":"Toftager, M. et al. Quality of life and psychosocial and physical well-being among 1,023 women during their first assisted reproductive technology treatment: secondary outcome to a randomized controlled trial comparing gonadotropin-releasing hormone (GnRH) antagonist and GnRH agonist protocols. Fertility and sterility 109, 154\u2013164, https:\/\/doi.org\/10.1016\/j.fertnstert.2017.09.020 (2018).","journal-title":"Fertility and sterility"},{"key":"65558_CR27","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1136\/bmj.325.7355.98","volume":"325","author":"DJ Torgerson","year":"2002","unstructured":"Torgerson, D. J. & Byford, S. Economic modelling before clinical trials. BMJ (Clinical research ed. 325, 98 (2002).","journal-title":"BMJ (Clinical research ed."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-65558-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-65558-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-65558-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T11:46:29Z","timestamp":1670327189000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-65558-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,26]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["65558"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-65558-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,26]]},"assertion":[{"value":"4 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8732"}}